Agenus/GSK malaria vaccine candidate shows success in children

Agenus Inc. (Nasdaq: AGEN), a Lexington biotech that makes a key ingredient being tested in vaccines for a range of diseases, saw a stock surge Tuesday after it showed promise in preventing a disease which kills more than half a million people a year worldwide, most of them children in Africa...